Pharmacological cognitive enhancement in pediatrics
- PMID: 29538047
- DOI: 10.1097/MOP.0000000000000615
Pharmacological cognitive enhancement in pediatrics
Abstract
Purpose of review: Given the pervasiveness of psychotropic medication in the youth population and an increasingly competitive culture regarding educational performance, children, teenagers, and/or their parents may increasingly seek psychotropic substances in an effort to enhance a student's cognitive abilities and/or academic performance. Physicians must become aware of this very important and clinically relevant issue and work to ensure that medications remain in the hands of patients seeking wellness and not enhancement.
Recent findings: The current article highlights findings on the pervasiveness of stimulant misuse and diversion in youth, the motivations and effects of stimulant use, health and legal consequences associated with use, and physician perceptions and preventive practices. Ethical concerns regarding pharmacological cognitive enhancement in pediatrics are also outlined - including coercion for nonusers, inequities in access, and threats to an individual's sense of self with regard to authenticity and autonomy.
Summary: Pharmacological cognitive enhancement in pediatrics will become a larger, clinically relevant issue in the coming years. Physicians who care for children and adolescents must become more aware of this issue. Given the myriad health, legal, and ethical concerns, clinicians should discourage use of pharmaceuticals for enhancement purposes in the pediatric population.
Similar articles
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Physician practices to prevent ADHD stimulant diversion and misuse.J Subst Abuse Treat. 2017 Mar;74:26-34. doi: 10.1016/j.jsat.2016.12.003. Epub 2016 Dec 21. J Subst Abuse Treat. 2017. PMID: 28132697
-
Performance enhancing drugs in sports and the role of doctors: are there guidelines?Indian J Med Ethics. 2013 Apr-Jun;10(2):115-7. doi: 10.20529/IJME.2013.034. Indian J Med Ethics. 2013. PMID: 23697492
-
Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.Neurology. 2013 Mar 26;80(13):1251-60. doi: 10.1212/WNL.0b013e318289703b. Epub 2013 Mar 13. Neurology. 2013. PMID: 23486879 Review.
-
Off-label use of medicine in pediatrics: focus on gastrointestinal diseases.Curr Opin Pediatr. 2013 Oct;25(5):612-7. doi: 10.1097/MOP.0b013e328363ed4e. Curr Opin Pediatr. 2013. PMID: 23995427 Review.
Cited by
-
Concept generation of cognitive enhancement: healthcare professionals' approach towards the impact and utilization of cognitive enhancers in academic context.Heliyon. 2021 Oct 4;7(10):e08118. doi: 10.1016/j.heliyon.2021.e08118. eCollection 2021 Oct. Heliyon. 2021. PMID: 34660928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials